Oppenheimer Thinks Agile Therapeutics' Stock is Going to Recover
alphanewsstream
2021-05-05 10:31
Oppenheimer Thinks Agile Therapeutics' Stock is Going to Recover
Oppenheimer analyst Leland Gershell maintained a Buy rating on Agile Therapeutics (AGRX) today and set a price target of $6.00.
The post Oppenheimer Thinks Agile Therapeutics Stock is Going to Recover appeared first on Smarter Analyst.
Oppenheimer analyst Leland Gershell maintained a Buy rating on ...

https://www.smarteranalyst.com/new-blurbs/oppenheimer-thinks-agile-therapeutics-stock-is-going-to-recover/

#SmarterAnalyst
Hide Comments Comments (0)

You must login before you can post a comment.